Mylan Acquires King For $4B In Move Toward Branded Drugs
Mylan Laboratories, the largest maker of generic drugs in the U.S., has agreed to acquire competitor King Pharmaceuticals for about $4 billion in a move widely seen as a part of...To view the full article, register now.
Already a subscriber? Click here to view full article